This inventor holds 63 USPTO granted patents and 8 published patent applications and 1 EPO patent, primarily in Antimicrobial Agents (CPC class C07D). Top assignees: Rutgers, The State University of New Jersey, Alteon Incorporated, University of Medicine and Dentistry of New Jersey. Active years: 1998-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Inventors with similar research interests:
Location History:
- Princeton Jct., NJ (US) (1998 - 1999)
- Princeton Junction, NJ (US) (1998 - 2013)
- Princeton Jct, NJ (US) (2015)
- New Brunswick, NJ (US) (2010 - 2024)
Company Filing History:
57 out of 1,498 
4 out of 55 
4 out of 272 
Years Active: 1998-2024
Areas of Expertise:
Title: Edmond Joseph LaVoie: Innovator in Bacterial Infections Treatment
Introduction
Edmond Joseph LaVoie, based in Princeton Junction, New Jersey, is a prolific inventor with a remarkable portfolio of 60 patents. His work primarily focuses on the field of medicinal chemistry, specifically in developing compounds that serve as efflux pump inhibitors crucial for treating bacterial infections. LaVoie's innovations reflect a deep understanding of pharmacology and a commitment to advancing healthcare.
Latest Patents
Among LaVoie's latest patents are the development of indole derivatives as efflux pump inhibitors. The disclosed compounds can significantly contribute to medical treatments aimed at preventing or treating bacterial infections. Another noteworthy patent involves bacterial efflux pump inhibitors, wherein LaVoie outlined compounds and methodologies that demonstrate the potential of these innovations in the field of antibacterial therapies.
Career Highlights
LaVoie's career encompasses significant contributions to both academia and industry. He has held key positions at prestigious institutions, including Rutgers, the State University of New Jersey, and Alteon Incorporated. His extensive experience in these organizations has enabled him to merge theoretical research with practical applications, fostering advancements in pharmaceutical science.
Collaborations
Throughout his career, LaVoie has collaborated with notable peers, including Leroy Fong Liu and Ajit S Parhi. These partnerships have enhanced the research output and facilitated the exchange of innovative ideas pivotal in the development of his numerous patents.
Conclusion
Edmond Joseph LaVoie stands out as a noteworthy inventor whose work has significantly impacted the treatment of bacterial infections. With a robust portfolio and a collaborative spirit, LaVoie's contributions exemplify the essence of innovation in the medical field, promising a brighter future in combating antibiotic resistance.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile